Latest news with #aesthetics
Reuters
6 days ago
- Business
- Reuters
Swiss skin care firm Galderma raises sales outlook for 2025, shares jump
ZURICH, July 24 (Reuters) - Swiss skin care company Galderma (GALD.S), opens new tab on Thursday raised its outlook for 2025 after posting net sales growth of 12.2% during the first six months, driven by double-digit growth in the United States and international markets. Galderma said it expected net sales growth at constant currency to be between 12% and 14% this year, up from previous guidance of 10-12%, as it confirmed guidance on its core EBITDA margin of around 23%, again at constant currency. The company, which floated on the Swiss stock exchange in March 2024, has seen its shares jump by over 140% since then, and the stock leapt by more than 8% after opening. Chief Executive Officer Flemming Ornskov said the firm's dermatological skincare and injectable aesthetics and in particular its therapeutic dermatology arms had all posted robust growth as Galderma continued to expand its market share. Ornskov was speaking to Reuters from Miami as the company establishes its new U.S. headquarters there, and he pointed to the growing importance of the United States, where Galderma generates more than 40% of its sales. "The U.S. is super important to us, and we continue to build out both our infrastructure and our manufacturing there," Ornskov said. Galderma said it saw as manageable its exposure to announced U.S. tariffs, which are fully factored-in for the full-year, and was confident that it could absorb some further tariff impact and consumer demand-related deterioration.
Yahoo
23-07-2025
- Business
- Yahoo
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand
Acquisition strengthens Obagi Medical's product portfolio with proven, scientifically backed, injectable portfolio New products position Obagi Medical at the forefront of health, beauty and aesthetics convergence LONDON, July 23, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) ('Waldencast'), a global multi-brand beauty and wellness platform, today announced that it has acquired Novaestiq Corp. (Novaestiq), a growth-oriented aesthetic and medical dermatological innovations company, as well as the U.S. rights to the Saypha® line of hyaluronic acid (HA) injectable gels. The strategic acquisition expands Obagi Medical's offerings beyond U.S. medical-grade skincare, a market projected to be $2.2 billion by 2029, into the growing U.S. dermal filler market, projected to reach $2 billion in market size by 2029, effectively doubling its addressable market.1 The move marks a pivotal step in positioning Obagi Medical as an industry leader in integrated skincare and aesthetic solutions. 'We are excited to further diversify Obagi Medical's portfolio of medical-grade skincare with consumer centric, in-office injectable procedures through the introduction of the Obagi Medical Saypha® ChIQ™ and MagIQ™ lines of injectable HA gels,' said Michel Brousset, Co-Founder and CEO of Waldencast. 'Adding proven products into our portfolio increases our addressable market and allows us to deliver solutions for professionals and patients seeking both skincare and aesthetic treatments, all under the trusted Obagi Medical brand.' Obagi Medical's philosophy advocates for a holistic, science-driven approach where potent skincare and professional procedures work in tandem to achieve and maintain optimal skin health and a youthful appearance. These injectable products will play a pivotal role in the evolution of Obagi Medical into an end-to-end, synergistic solution that integrates medical-grade skincare with aesthetic treatments to deliver enhanced outcomes, prolonged results, and greater patient satisfaction. Beyond the two current offerings, the Novaestiq transaction provides access to a future pipeline of novel injectables in North America. Saypha®,2 currently undergoing U.S. Food and Drug Administration (FDA) approval, is recognized globally as a proven, safe and efficacious HA injectable with high levels of patient satisfaction. The new Obagi Medical injectable portfolio is supported by an industry-leading clinical program that reflects the brand's commitment to science-backed innovation. Core pivotal studies are more than twice the size of typical nasolabial fold (NLF) and midface trials and include the highest representation of Fitzpatrick Skin Types I, V, and VI – underscoring Obagi Medical's mission to provide effective solutions for all skin types and tones. Saypha® is distinguished by its proprietary technology delivering advanced HA treatments through a stable 3D matrix designed to provide natural-looking results with optimally balanced gel characteristics. This technology powers a portfolio of clinically proven products that lead in multiple performance categories including high HA content at injection, ideal gel distribution, and consistent injection force and swelling behavior. Saypha®, a product of Croma-Pharma GmbH, is developed and manufactured in Austria and marketed in over 80 countries, leveraging 40 years of expertise in HA-based treatments with more than 110 million syringes produced. This global reach and deep market insight allow for the delivery of trusted, personalized care to patients and professionals worldwide. 'We believe that great results start with great skincare and are perfected with great after care,' said Dr. Suzan Obagi, Chief Medical Director at Obagi Medical. 'By combining Obagi Medical skincare with injectable procedures under the guidance of a qualified professional, patients can achieve more significant, longer-lasting, and natural-looking results. This acquisition also allows our professionals to offer patients more personalized, higher quality and safer products that their customers are looking for.' Obagi Medical's vision is to become the #1 Dermatological Mega Brand uniquely serving all the needs of physicians, patients and consumers globally. It is already the fastest-growing U.S. professional-skincare brand among the top ten in its category.3 This momentum is powered by a three-pronged strategy: anchoring products in dermatological science, introducing breakthrough innovations, and expanding its global reach. Brousset added, 'We are thrilled to introduce this new offering that will strengthen Obagi Medical's market position, drive innovation, and create new growth opportunities in our fast-evolving industry. We see an accelerating global convergence of health, beauty, and aesthetics – an intersection where Obagi Medical is uniquely positioned to lead. We also plan to leverage this acquisition to expand Obagi Medical's footprint.' Transaction DetailsUnder the terms of the definitive agreement relating to the transaction, Waldencast has agreed to acquire Novaestiq in exchange for (1) certain amount of cash payable at closing, (2) certain additional ongoing royalties based on net sales of Saypha® products, and (3) the contingent issuance of Waldencast class A shares (equal to approximately 7% of Waldencast's fully diluted class A shares), based on the receipt of FDA approval relating to the Saypha® products (triggering the issuance of 3,273,000 Waldencast class A shares) and the achievement of cumulative net revenue thresholds of (a) $100 million (triggering the issuance of an additional 3,273,000 Waldencast class A shares) and (b) $200 million (triggering the further issuance of 3,273,000 Waldencast class A shares), respectively, reflecting meaningful long-term commercial targets, with (a) and (b) being earnable until June 20, 2031. The details of the transaction will be summarized in more detail in a Form 6-K that Waldencast will file with the U.S. Securities and Exchange Commission (the 'SEC') following this press release. About WaldencastFounded by Michel Brousset and Hind Sebti, Waldencast's ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast's vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand's distinct DNA. The first step in realizing its vision was the business combination with Obagi Medical and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: . About Obagi MedicalObagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi Medical products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024,3 Obagi Medical empowers individuals to achieve healthy, beautiful skin. More information about Obagi is available on the brand's website, 1In preparing for this transaction, Waldencast engaged management consulting services from a reputed global consulting firm. 2Saypha® products are not approved medical devices, and each product has a premarket approval (PMA) application under review by the FDA. 3Among the Top 10 Professional Skin Care Brands in the U.S., according to Kline's 2024 Global Professional Skin Care Series (China, Europe and the U.S.). AdvisorsHolland & Knight LLP is serving as Waldencast's legal advisor, with support from Skadden, Arps, Slate, Meagher & Flom LLP. Experium Capital Advisers is serving as Waldencast's financial advisor. Forward-Looking StatementsThis press release contains certain forward-looking statements within the meaning of the federal securities laws, including statements regarding the intended benefits of the transaction with Novaestiq, the ability to obtain FDA approval for Saypha®, the contingent issuance of Waldencast class A shares, and the growth strategies of Waldencast, including Obagi Medical and Novaestiq. These forward-looking statements generally are identified by the words 'estimates,' 'projects,' 'expects,' 'anticipates,' 'forecasts,' 'plans,' 'intends,' 'believes,' 'seeks,' 'may,' 'will,' 'would,' 'should,' 'future,' 'propose,' 'target,' 'goal,' 'objective,' 'outlook' and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of Waldencast, Obagi Medical and Novaestiq that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include, but are not limited to: (i) the inability to recognize the anticipated benefits of the transaction; (ii) the inability to obtain FDA approval for one or both of the Saypha® products; (iii) the general impact of geopolitical events, including the impact of current wars, conflicts and other hostilities; (iv) the overall economic and market conditions, sales forecasts and other information about Waldencast's possible or assumed future results of operations or our performance; (v) changes in general economic conditions; (vi) the impact of any international trade or foreign exchange restrictions, the imposition of new or increased tariffs, foreign currency exchange fluctuations; (vii) that the price of Waldencast's securities may be volatile due to a variety of factors, including Waldencast's, Obagi Medical's or Novaestiq's inability to implement their business plans; and (viii) the ability to implement Waldencast's strategic initiatives and continue to innovate Obagi Medical's existing products and anticipate and respond to market trends and changes in consumer preferences. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the 'Risk Factors' section of Waldencast's Annual Report on Form 20-F for the year ended December 31, 2024, filed with the SEC on March 20, 2025, or in other documents that may be filed or furnished by Waldencast from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Waldencast assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Contacts InvestorsICRinvestors@ MediaICRwaldencast@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
The National
17-07-2025
- Entertainment
- The National
Weekly UAE museum and gallery guide: A painted Lamborghini and art with raw meat
A painted Lamborghini, sausages crafted from ceramics and wooden panels painted in gold – this week's round-up of exhibitions challenge conventional aesthetics with their use of unlikely materials and forms. Lebanese artist Ihab Ahmad paints with his non-dominant hand, letting go of painterly control in favour of spontaneity. The artists presenting at Rarares Art Gallery use gold leaf, ceramics and fabrics to explore transformation and femininity. Indian artist Richi Bhatia, meanwhile, uses fish scales and raw meat to explore food systems. Here are three exhibitions to see this week. I put my brain on pause! at Firetti Contemporary Every artist reaches a point when they question their process, their practice and even themselves. Lebanese artist Ihab Ahmad rose to the challenge by disrupting his entire approach. I Put My Brain on Pause! is the result of this experiment. Firetti Contemporary describes the exhibition as 'a deeply personal body of work that embraces instinct, vulnerability and emotional surrender'. Works that use oil on linen and spray paint show smiling faces (a first in Ahmad's work) as reflections of personal connections and memories. But the centrepiece of the exhibition, a work created in collaboration with Lamborghini Dubai, is a Huracan Spyder decked with whimsical patterns and figures, similar to those on the surrounding canvases. Monday to Sunday, 11am-7pm; until August 20; Alserkal Avenue, Dubai Elysian Awakening of Powerful Spring at Rarares Art Gallery This group exhibition is exclusively dedicated to women artists, spanning generations, geographies and practices. Established names such as Emirati artist Fatma Lootah and Rome-born artist Barbara Duran explore identity and transformation through abstract forms, light and textured surfaces. Duran's Sortilegio series, for instance, presents wooden panels layered with gold and silver pigments to evoke light. Emerging artists such as Emirati Sara Alkhayyal and Egyptian Zeina Abdullah revisit regional heritage through interesting use of materials and visual language. The exhibition, at its core, is a celebration of the contributions of women in contemporary art, exploring emotional depth and imaginative vision. Monday to Sunday, 10am-10pm; until August 31; Dubai International Financial Centre Antevasin: The one who sits at the border of two worlds at Gallery Isabelle Embodied research is central to artist Richi Bhatia's practice. Living with a skin condition, for instance, prompted an exploration of fish scales as an artistic material. Ultimately, it also led her to question our food systems and consumption habits. In The Animals, The Bodies, and Coefficient of Time, she constructs temporary-scale shelters from fish scales and stainless steel structures. In Prone to Change… she constructs a bundle of stringed sausages from ceramics. In Table - Bed II, she puts together animal hide, hair, bottled water residue, pearl head pins, ashwagandha and meat-referencing ceramics. The works may evoke discomfort – and that is partly the point. As the gallery describes: 'Food is both a sustainer of life and a site of suffering.'
Daily Mail
09-07-2025
- Health
- Daily Mail
Nurse shows surprising results of having Botox on ONE side of her face
A nurse had anti-wrinkle injections on one side of her face only to show others how the treatment really changes your looks. Brittany Krautheim, 41, from Queenstown, Maryland, has spent the past 21 years working as an esthetic nurse practitioner. In recent months she decided to conduct an experiment in which she received Botox on half her face and documented the outcome online in the hopes of enlightening others about the pros and cons of injectables. Brittany said: 'I injected the entire left side of my face (upper and lower). Areas included the 11s, forehead, crows feet, downturned smile, and platysmal sheath/bands. 'I stayed true to FDA on label dosing (but half since it was only half my face). Between my brows, I did 10 units, my forehead 10 units, my left eye 12 units, left downturned smile five units, left platysmal bands/sheath 18 units.' And while some may think that the results would be dramatic, they're actually more subtle. She said strangers often tell her they would not have noticed that she had Botox in half her face if she hadn't pointed it out. And according to the expert, that's a good thing. 'I think the biggest misnomer about Botox is that it's going to change how you look,' she explained. 'However, that's not really the goal. Good Botox allows you to keep your normal appearance while subtly reducing facial muscle contractions that cause wrinkles due to repetition. 'I think the results speak for themselves. I think both sides of my face look "natural."' Facing up: She had injections in the upper and lower areas, including her forehead and crows feet; pictured before (left) and after (right) While the differences aren't that noticeable yet, she said she believed that if she continued on with the project, the changes to her face would become more pronounced. 'Over time if I continued this project, let's say over the course of a year, one side of my face would have significantly more set in fine lines and wrinkles because the facial muscles are constantly contracting in the same place.' According to Brittany, there have been some negative side effects. 'It is strange to only have half of your face injected and I will say that around the third week I was getting headaches and having trouble focusing my vision because of the imbalance.' Brittany has been documenting the endeavor on TikTok, where her videos have racked in millions of views. It has sparked a fierce debate about Botox, with some claiming in the comments section that they prefer the 'natural' side and that it made them not want to get the injectables, while others writing that it has inspired them to go get some. In the end, the nurse practitioner said she hopes people can use her experiment to make 'informed and educated' decisions when it comes to cosmetic enhancements. And she slammed any beliefs that she did this to gain more customers. 'It's frustrating when people comment on these types of posts that I'm just trying to promote something or sell something. 'My goal is to educate and to develop a relationship with each person that I encounter. 'If at the end of that conversation, they feel like an esthetic treatment is in their best interest, then great. 'If that's not the case, that's OK too! The "right" choice, much like beauty, is in the eye of the beholder.' She also shared some advice to women who may feel insecure about their decision to get Botox. 'Every woman should have the freedom to take care of themselves in a way that feels best to them without shame or judgment. 'As we grow into our age and beauty remember that there is no one look or set of rules. 'While some of us choose to smooth our lines while others don't, remember that we are all beautiful in our own right and we all deserve to feel seen and supported.'
Daily Mail
08-07-2025
- Health
- Daily Mail
EXCLUSIVE I got Botox on half my face to show others how it really affects your looks... here are the results
A nurse who got Botox injected on only one side of her face to show others how it really affects your looks has revealed the shocking results. Brittany Krautheim, 41, from Queenstown, Maryland, has spent the last 21 years working as an aesthetic nurse practitioner. And over the course of her two decades in the beauty industry, she has learned a lot of tips and tricks to ensuring your skin stays healthy. Over the last few years, she has become a viral social media star by sharing advice to maintaining a youthful appearance as you age to TikTok and Instagram. She explained during an exclusive chat with the Daily Mail that she's been told time and time again by her patients that she's 'great at explaining medical information in real world terms.' 'So it felt natural to turn my social media platforms into a place where people can get real and honest information,' she explained. 'Many people are hesitant to make a consultation with an aesthetics provider, but most have questions that they are too afraid to ask. 'I wanted to bridge that gap. I wanted my platform to be the place to go for honest real life educational content. No BS.' In recent months, she decided to conduct an experiment in which she received Botox on half her face and documented the outcome online in the hopes of enlightening others about the pros and cons of the injectables. 'I injected the entire left side of my face (upper and lower). Areas included the 11s, forehead, crows feet, downturned smile, and platysmal sheath/bands,' she shared. 'I stayed true to FDA on label dosing (but half since it was only half my face). Between my brows, I did 10 units, my forehead 10 units, my left eye 12 units, left downturned smile five units, left platysmal bands/sheath 18 units.' And while some may think that the results would be dramatic, they're actually more subtle. She said strangers often tell her they would not have noticed that she had Botox in half her face if she hadn't pointed it out. And according to the expert, that's a good thing. 'I think the biggest misnomer about Botox is that it's going to change how you look,' she explained. 'However, that's not really the goal. Good Botox allows you to keep your normal appearance while subtly reducing facial muscle contractions that cause wrinkles due to repetition. 'I think the biggest misnomer about Botox is that it's going to change how you look,' she explained. 'However, that's not really the goal.' She's seen after getting the Botox 'I think the results speak for themselves. I think both sides of my face look "natural."' While the differences aren't that noticeable yet, she said she believed that if she continued on with the project, the changes to her face would become more pronounced over time. 'Overtime if I continued this project, let's say over the course of a year, one side of my face would have significantly more set in fine lines and wrinkles because the facial muscles are constantly contracting in the same place,' she dished. According to Brittany, there have been some negative side effects. 'It is strange to only have half of your face injected and I will say that around the third week I was getting headaches and having trouble focusing my vision because of the imbalance,' she admitted. Brittany has been documenting the endeavor on TikTok, where her videos have racked in millions of views. It has sparked a fierce debate about Botox, with some claiming in the comment section that they prefer the 'natural' side and that it made them not want to get the injectables, while others writing that it has inspired them to go get some. In the end, the nurse practitioner said she hopes people can use her experiment to make 'informed and educated' decisions when it comes to cosmetic enhancements. Brittany has been documenting the endeavor on TikTok, where her videos have racked in millions of views. She's seen left before and right after the injections And she slammed any beliefs that she did this to gain more customers. 'It's frustrating when people comment on these types of posts that I'm just trying to promote something or sell something,' she said. 'My goal is to educate and to develop a relationship with each person that I encounter. 'If at the end of that conversation, they feel like an aesthetic treatment is in their best interest, then great. 'If that's not the case, that's okay too! The "right" choice, much like beauty, is in the eye of the beholder.' She also shared some advice to women who may feel insecure about their decision to get Botox. She stressed, 'It is just so much more common than everyone thinks. 'So many people get Botox and don't talk about it in their social groups and like I said earlier, good Botox isn't highly detectable.
